CDKN2B and hepatocellular carcinoma: However, the dual treatment with cytokines and targeted therapies induced significantly greater senescence as evidenced by SA-β-gal assay (Figure 4A, p < 0.01) and increased expression of p15INK4b in HCC-1419 cells (Figure 4B) and JIMT-1 cells (Figure 4C).